Effect of Maraviroc on Endothelial Function in HIV-Infected Patients
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the potentially beneficial aspects of CCR5
inhibition on inflammation and endothelial function as measured by brachial artery reactivity
in antiretroviral treated HIV patients with an undetectable viral load.
Phase:
Phase 3
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) Pfizer